Company Filing History:
Years Active: 2013-2014
Title: Milton T. Stubbs: Innovator in Glutaminyl Cyclase Research
Introduction
Milton T. Stubbs is a prominent inventor based in Halle/Saale, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of glutaminyl cyclase. With a total of 3 patents to his name, Stubbs has been instrumental in advancing our understanding of this important enzyme.
Latest Patents
Stubbs' latest patents include groundbreaking work on the crystal structure of glutaminyl cyclase. This patent details novel crystal structures of both human and murine glutaminyl cyclase (QC, EC 2.3.2.5), along with methods for preparing these crystals. The research also explores the use of these crystal structures for identifying inhibitors of human and murine glutaminyl cyclase. Another significant patent focuses on the crystal structure of isoglutaminyl cyclase, which comprises human isoglutaminyl cyclase characterized by a space group of P1211 and specific unit cell dimensions.
Career Highlights
Milton T. Stubbs is currently associated with Probiodrug AG, a company dedicated to developing innovative therapies for neurodegenerative diseases. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.
Collaborations
Throughout his career, Stubbs has collaborated with notable colleagues, including Stephan Schilling and Jens-Ulrich Rahfeld. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Milton T. Stubbs stands out as a key figure in the field of glutaminyl cyclase research, with a focus on innovative crystal structures that hold promise for future therapeutic developments. His contributions continue to influence the scientific community and pave the way for advancements in biochemistry.